| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000012867 |
| Receipt No. | R000014966 |
| Scientific Title | The Effect of Patient Education in Initial Treatment of Children with Atopic Dermatitis by Pediatric Allergy Educator |
| Date of disclosure of the study information | 2014/01/20 |
| Last modified on | 2021/02/01 (Ver. 5) |
| Basic information | ||
| Public title | The Effect of Patient Education in Initial Treatment of Children with Atopic Dermatitis by Pediatric Allergy Educator | |
| Acronym | The Effect of Patient Education for Chilren with Atopic Dermatitis by Pediatric Allergy Educator | |
| Scientific Title | The Effect of Patient Education in Initial Treatment of Children with Atopic Dermatitis by Pediatric Allergy Educator | |
| Scientific Title:Acronym | The Effect of Patient Education for Chilren with Atopic Dermatitis by Pediatric Allergy Educator | |
| Region |
|
|
| Condition | |||||
| Condition | Children with Atopic Dermatitis | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | To test whether pediatric allergy educator leads the effectiveness of patient education at the stage of initial treatment for pediatric patients with atopic dermatitis. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | SCORAD, at baseline, 10 weeks later |
| Key secondary outcomes | DFI(Family impact of childhood eczema questionnaire)
QPCAD(Quality of Life in Primary Caregivers if children with Atopic Dermatitis) The number of Skin care Amout of steroid,tacrolimus ointment and moisturizer usage at baseline, 2 weeks, 6 weeks, 10 weeks later |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | Institution is considered as a block. |
| Blocking | |
| Concealment | Central registration |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Standard Therapy and Patient education by pediatric allergy educator. | ||
| Interventions/Control_2 | Standard Therapy and Patient education by pediatrician or/and allergist. | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Moderate or sever eczema according to Guidelines for Management of Atopic Dermatitis 2012.
2)To be treated as an outpatient at the research facility. 3)The primary caregiver is the patients,and either one of the parents can visit to the outpatient. |
|||
| Key exclusion criteria | 1)Need emergency admission.
2)Can not practice Proactive Therapy. 3)In-charge doctor judges. |
|||
| Target sample size | 120 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tokyo Metropolitan Children's Medical Center | ||||||
| Division name | Department of Allergy | ||||||
| Zip code | |||||||
| Address | 2-8-29,Musashidai,Fuchu,Tokyo,Japan | ||||||
| TEL | 042-300-5111 | ||||||
| akira_akasawa@tmhp.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tokyo Metropolitan Children's Medical Center | ||||||
| Division name | Department of Allergy | ||||||
| Zip code | |||||||
| Address | 2-8-29,Musashidai,Fuchu,Tokyo,Japan | ||||||
| TEL | 042-300-5111 | ||||||
| Homepage URL | |||||||
| masuko.ik@gmail.com | |||||||
| Sponsor | |
| Institute | Tokyo Metropolitan Children's Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Environmental Restoration and Conservation Agency |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Fukuoka National Hospital |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京都立小児総合医療センター(東京都)、国立病院機構福岡病院(福岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000014966 |